Bioreactors Market size was estimated at $1,409.3 Million in 2019 and is expected to reach $2,226.2 Million by 2027, growing at a CAGR of 6.75% during the forecast period of 2020 to 2027.
Bioreactors and fermenters are devices for creating a better environment for the growth of microorganisms or extracting biochemically active things derived from organisms like these. These are large-sized fermenters that are used globally in the biopharmaceutical industry for the production of biologics such as monoclonal antibodies, DNA proteins, and vaccines at a wide scale. In the recent few years, the procedure of wide-scale biomanufacturing has become more specific owing to better technology and the easy availability of devices big enough to make prominently large volumes of biologics due to rise in expression systems, cultures and cell lines.
This sort of progress has boosted the demand for equipment as a requirement for small volume and multi-product capabilities have allowed facilities to adjust unit operations which are made according to demand without incurring wastage or extra expenditure. According to product type, the market for bioreactors and fermenters which has been further divided in the report into single-use bioreactors and multiple-use bioreactors. Of these, the division of single-use bioreactors is attaining more popularity than multiple ones as the former ones which also benefit such as lower capital expenditure, smaller footprint, fast assembling, and fall in the risk of cross-contamination. The rise in demand for single-use bioreactors is anticipated to rise as cost pressures from health care providers rise and new markets enter the industry.
Bioreactors and Fermenters Market Growth and Trends
The high efficiency of bioreactors and fermenters for creating a proper environment for the growth of microorganisms or fostering biochemically active substances resulting from such organisms, generates a high demand for them. Their wide use in biopharmaceutical industry for producing biologics like monoclonal antibodies, vaccines, and recombinant proteins at a large scale, especially during the pandemic situation currently fosters their market growth at a steep rate. In the last few years, large-scale bio-manufacturing due to technological advancements and easy availability of machines large enough to produce significantly high volumes of biologics due to progress in expression systems, cultures, cell lines, has ensured high growth in demand for bioreactors and fermenters, since demand for small volume and multi-product capabilities has aided facilities to tweak unit operations based on demand without having to incur wastages and extra expenditure. The single-use segment of bioreactors is increasing in popularity in comparison with multiple-use bioreactors as the former offer advantages such as smaller footprint, lower capital expenditure, quick assembly, and reduction in risk of cross contamination. Demand for single-use bioreactors is anticipated to rise further as cost pressures from the healthcare providers rise and new markets open. This, however, would require a significant level of flexibility and speed in construction, which is not possible with traditional bioreactors. However, the segment of multiple-use bioreactors has also been a significant contributor of revenue to the global market, and the well-established segment is expected to continue leading the global market and grow at a sustained pace, even if it may be at a lower growth rate in comparison with the segment of single-use bioreactors.
High cost of production involved in manufacturing these bioreactors and fermenters can be a deterrent to growth of the market, as it requires constant technological innovation for upgrading features in these high-performing, heavy machinery.
Bioreactors and Fermenters Market Competition
Key companies operating in this industry are Sartorius AG (BBI), Thermo Fisher, Merck KGaA, Danaher (Pall), Eppendorf AG, Praj Hipurity Systems, Pierre Guerin (DCI-Biolafitte), ZETA, Applikon, Biotechnology, Bioengineering AG, Infors HT and Solaris.
Coverage Highlights
• Bioreactors and Fermenters Market Revenue Estimation and Forecast (2020 – 2027)
• Production Estimation and Forecast (2020 – 2027)
• Sales/Consumption Volume Estimation and Forecast (2020 – 2027)
• Breakdown of Revenue by Segments (2020 – 2027)
• Breakdown of Production by Segments (2020 – 2027)
• Breakdown of Sales Volume by Segments (2020 – 2027)
• Gross Margin and Profitability Analysis of Companies
• Business Trend and Expansion Analysis
• Import and Export Analysis
Bioreactors and Fermenters Market Segment Analysis
Product Outlook (Revenue, USD Million, 2020 - 2027)
• Single-use Bioreactors
• Multiple-use Bioreactors
Application Outlook (Revenue, USD Million, 2020 - 2027)
• CROs
• Academic and Research Institutes
• Others
Country (Revenue, USD Million, 2020 - 2027)
North America
• United States
• Canada
• Mexico
Asia-Pacific
• China
• Japan
• South Korea
• India
• Philippines
• Malaysia
• Australia
• Rest of Asia Pacific
Europe
• Italy
• Spain
• France
• UK
• Germany
• Belgium
• Netherlands
• Switzerland
• Russia
• Rest of Europe
South America
• Brazil
• Peru
• Chile
• Rest of South America
Middle East and Africa
• Iran
• Israel
• Saudi Arabia
• Turkey
• Africa
Bioreactors and Fermenters Market Companies
• Sartorius AG (BBI)
• Thermo Fisher
• Merck KGaA
• Danaher (Pall)
• Eppendorf AG
• Praj Hipurity Systems
• Pierre Guerin (DCI-Biolafitte)
• ZETA
• Applikon Biotechnology
• Bioengineering AG
• Infors HT
• Solaris
